On September 3, 2025, Denis Pasler, Acting Governor of the Sverdlovsk Region, paid a working visit to Medsintez Plant LLC, one of the systemic companies of the Russian Federation. The purpose of the visit was to assess the scale of import substitution in pharmaceutical production, get acquainted with the latest developments of the plant, and discuss prospects for the regional pharmaceutical industry.
In 2025, the annual Smartpharma® Awards ceremony took place in Moscow. The drug TRIAZAVIRIN® was named one of the top three winners in the category Domestic Oral Antiviral Drug for Influenza and Other ARVIs.
Experts from the Russian Ministry of Health have included the TRIAZAVIRIN® antiviral drug in the guidelines "Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection COVID-19" (version No. 19 dated 27/5/2025).
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic "Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction". The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.